By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ono Pharmaceutical Company, Ltd. 

2-1-5 Doshomachi
Osaka    541-8526  Japan
Phone: 06-6222-5551 Fax:



Company News
How a $150,000 Drug Created with Bristol-Myers Squibb (BMY) Saved Ono Pharma 3/4/2016 7:06:29 AM
Ono Pharmaceutical Company, Ltd. Transforms Its High-Throughput Screening With Genedata AG Screener 2/23/2016 10:03:05 AM
Ono Pharmaceutical Company, Ltd. Selects Medidata To Power Clinical Trials Exploring Additional Cancer Indications For Immunotherapy Drug OPDIVO (Nivolumab) 1/27/2016 10:16:06 AM
Merus Reaches Pivotal Milestone In Bispecific Antibody Collaboration With Ono Pharmaceutical Company, Ltd. 4/8/2015 10:02:22 AM
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And Ono Pharmaceutical Company, Ltd. Announce Collaboration On Development Of PD-L1 Companion Diagnostic Test For Investigational Cancer Drug Opdivo(Nivolumab) 2/16/2015 8:53:21 AM
Ono Pharmaceutical Company, Ltd. And Gilead Sciences, Inc. (GILD) Announce Exclusive License Agreement To Develop BTK Inhibitor, ONO-4059, For The Treatment Of B-Cell Malignancies And Other Diseases 12/19/2014 11:44:30 AM
Ono Pharmaceutical Company, Ltd., Bristol-Myers Squibb Company (BMY), And Kyowa Hakko Kirin Announce Immuno-Oncology Clinical Collaboration Studying Opdivo (Nivolumab) And Mogamulizumab In Advanced Solid Tumors 12/10/2014 9:19:38 AM
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014 6:22:01 AM
Bristol-Myers Squibb Company (BMY) And Ono Pharmaceutical Company, Ltd. Announce Strategic Immuno-Oncology Collaboration In Japan, South Korea And Taiwan 7/24/2014 11:34:28 AM
Merck KGaA (MKGAF.PK) Terminates Multiple Schlerosis Drug License Agreement With Ono Pharmaceutical Company, Ltd. 6/17/2014 7:12:35 AM